Drawing for SUPRALAB

USPTO serial 79449444

SUPRALAB

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
DYER, ERIN ZASKODA
Law office
TMEG LAW OFFICE 103

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with SUPRALAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietary food supplements for medical purposes; amino acid compositions for use in the treatment of malnutrition; amino acid compositions for use in the treatment of protein deficiency; amino acids for medical purposes; analgesics; anti-inflammatories; antibiotics; antitussives; medicated candies; dietetic beverages adapted for medical purposes; medicated beverages; herb teas for medical use; bath tea for therapeutic purposes; herbal tea for medical purposes; collagen for medical purposes; food supplements for medical use; dietetic supplements for medical purposes; food supplements for therapeutic purposes; pharmaceutical tablets; digestives for pharmaceutical purposes; diuretics; enzyme preparations for medical purposes; enzymes for medical purposes; expectorants; plant extracts, other than essential oils, for pharmaceutical purposes; flour for pharmaceutical purposes; dietary fiber; laxatives; anticonvulsants; antidepressants; antidiabetic pharmaceuticals; homeopathic medicine; pharmaceutical preparations for treating gastrointestinal disorders; vasoconstrictors; copaiba extract based medicines; guaco-based medicines; mint for pharmaceutical purposes; oils for medical purposes; tanning pills; albuminous preparations for medical use; aloe vera preparations for pharmaceutical purposes; pharmaceutical preparations; nutraceutical preparations for therapeutic or medical purposes; vitamin preparations; fruit-based dietary supplements; fruit-based food supplements; protein-based food supplements; medicines for alleviating constipation; nutritional supplements containing vitamins and minerals for medical purposes; nutritional supplements in the form of food bars; food supplements in liquid form for medical purposes; powdered food supplements for medical purposes; açai powder dietetic supplements; copaiba powder dietary supplements; guarana powder dietary supplements; food supplements with a cosmetic effect; albumin food supplements; casein dietary supplements; enzyme dietary supplements; royal jelly food supplements; wheat germ dietary supplements; glucose dietary supplements; lecithin dietary supplements; yeast dietary supplements; brewer's yeast food supplements; brewer's yeast for use as food supplements; flaxseed dietary supplements; propolis dietary supplements; protein food supplements; whey protein food supplements; mineral food supplements; dietary supplements for humans and nutritional supplements.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026RFNTREFUSAL PROCESSED BY IB—
Aug 1, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 1, 2026RFRRREFUSAL PROCESSED BY MPU—
Jun 9, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 8, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2026DOCKASSIGNED TO EXAMINER—
May 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 8, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance